COMMERZBANK AG Call VALEO SA 31Dec99 (DE000CE4W5A1)

0.0101 0.0000 (0.00%)
Real-time Data EUR Disclaimer
Day's Range
0.0101 - 0.0101
52 wk Range
0.0000 - 0.0000
Prev. Close
0.0100
Open
0.0101
Volume
-
Average Vol.(3m)
-
1-Year Change
0%
Leverage
1:1
Strike Price
-
Calls & Puts
Call
Underlying
Valeo
Type
Certificate
Market
France
ISIN
DE000CE4W5A1
CUSIP
-
Asset Class
Equity
Certificate type
Turbo
Issue Date
-
Maturity Date
12/31/2099
Issue amount
-
Strong Sell Strong Buy Sell Neutral Buy
Buy
How do you feel today about COMMERZBANK AG Call VALEO SA 31Dec99?
or

COMMERZBANK AG Call VALEO SA 31Dec99 News & Analysis

  •  sizes=

    Societe Generale maintains Valeo at Hold, PT $20.00

    A Societe Generale analyst maintained Valeo (EPA: VLOF) at Hold and a price target of $20.00 from a prior price target of %currency%%price%. Prior to this rating, Valeo had 7 buy ratings,...

    • Investing.com
  •  sizes=

    Stifel maintains Valeo at Hold

    A Stifel analyst maintained Valeo (EPA: VLOF) at Hold and a price target of $21.00 from a prior price target of %currency%%price%. Prior to this rating, Valeo had 8 buy ratings, 11 hold...

    • Investing.com
  •  sizes=

    Jefferies maintains Valeo at Underperform

    A Jefferies analyst maintained Valeo (EPA: VLOF) at Underperform and a price target of $15.00 from a prior price target of %currency%%price%. Prior to this rating, Valeo had 7 buy...

    • Investing.com
  •  sizes=

    JPMorgan maintains Valeo at Overweight

    A JPMorgan analyst maintained Valeo (EPA: VLOF) at Overweight and a price target of $25.00. Prior to this rating, Valeo had 8 buy ratings, 9 hold ratings, and 1 sell ratings. For...

    • Investing.com
  •  sizes=

    JPMorgan maintains Valeo at Overweight

    A JPMorgan analyst maintained Valeo (EPA: VLOF) at Overweight and a price target of $25.00 from a prior price target of %currency%%price%. Prior to this rating, Valeo had 9 buy ratings,...

    • Investing.com
  •  sizes=

    Valeo Pharma earnings inline, Revenue beats in Q3

    Investing.com - Valeo (EPA:VLOF) Pharma reported on Tuesday third quarter {{erl-1187375||earnings that matched analysts' forecasts and revenue that topped expectations. Valeo Pharma...

    • Investing.com

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles